Biogen(BIIB) Spinoff Bioverativ(BIVV) Begins Trading On A When Issued Basis
Biogen(BIIB) enters the final days before its spinoff of Bioverativ(BIVV), its global hemophilia business, as the new company begins when issued trading under the ticker BIVV. After the close of business on February 1, Biogen shareholders as of January 17 will receive one share of Bioverativ for every two shares they own. The distribution is expected to be… Read More »